On the chart you can see the default numbers in dynamics for YanAn Bicon Pharmaceutical Listed Company (002411.SZ). Companys revenue shows the average of 3453.038 M which is 0.251 % gowth. The average gross profit for the whole period is 957.744 M which is 0.494 %. The average gross profit ratio is 0.250 %. The net income growth for the company last year performance is 0.599 % which equals 0.957 % % on average for the whole company history.,
Diving into the fiscal trajectory of YanAn Bicon Pharmaceutical Listed Company, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.206. In the realm of current assets, 002411.SZ clocks in at 6074.924 in the reporting currency. A significant portion of these assets, precisely 950.226, is held in cash and short-term investments. This segment shows a change of 0.128% when juxtaposed with last year's data. The debt profile of the company shows a total long-term debt of 231.948 in the reporting currency. This figure signifies a year_over_year change of -0.636%. Shareholder value, as depicted by the total shareholder equity, is valued at 5773.341 in the reporting currency. The year over year change in this aspect is -0.243%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 4260.171, with an inventory valuation of 788.22, and goodwill valued at 1614.72, if any. The total intangible assets, if present, are valued at 531.04. Account payables and short-term debt are 1892.02 and 1552.99, respectively. The total debt is 1784.94, with a net debt of 907.84. Other current liabilities amount to 4597.03, adding to the total liabilities of 8698.72. Lastly, the referred stock is valued at 0, if it exists.
The financial landscape of YanAn Bicon Pharmaceutical Listed Company has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of 3.597. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 0 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to 842831286.000 in the reporting currency. This is a shift of 12.830 from the previous year. In the same period, the company recorded 350.08, -10.27, and -3338.95, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -2021.41 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 2222.46, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.
YanAn Bicon Pharmaceutical Listed Company's revenue saw a change of 0.058% compared with the previous period. The gross profit of 002411.SZ is reported to be 2031.19. The company's operating expenses are 1719.49, showing a change of 100.691% from the last year. The expenses for depreciation and amortization are 350.08, which is a -0.132% change from the last accounting period. Operating expenses are reported to be 1719.49, which shows a 100.691% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.719% year-over-year growth. The operating income is 342.95, which shows a -0.719% change when compared to the previous year. The change in the net income is 0.599%. The net income for the last year was -1054.7.
